Vericel (VCEL) Total Debt Growth (3y) (2013 - 2018)
Vericel (VCEL) Total Debt Growth (3y) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 50.25% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 25.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 497.52% |
| Jun 30, 2018 | 474.60% |
| Mar 31, 2018 | 456.63% |
| Dec 31, 2017 | 235.37% |
| Sep 30, 2017 | 302.23% |
| Jun 30, 2017 | 59.54% |
| Mar 31, 2017 | 1,617.07% |
| Dec 31, 2016 | 413.20% |
| Sep 30, 2016 | 724.65% |
| Jun 30, 2016 | 39.88% |
| Mar 31, 2016 | 28.82% |
| Dec 31, 2015 | 21.08% |
| Sep 30, 2015 | 18.24% |
| Jun 30, 2015 | 15.54% |
| Mar 31, 2015 | 13.17% |
| Dec 31, 2014 | 78.76% |
| Sep 30, 2014 | 15.23% |
| Jun 30, 2014 | 157.75% |
| Dec 31, 2013 | -71.34% |